Optima Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Optima Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-778	Closed	-$2.62K	–	723
2025 Q4	$2.62K	Buy	+778	New	+$2.02K	﹤0.01%	720

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Optima Capital's IRWD Position: Q1 2026 in Review

Optima Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 778 shares — an estimated $2.62K sold.

Optima Capital first reported a position in IRWD in Q4 2025 and held it in 1 quarter. The position peaked at $2.62K in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Optima Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 778 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $2.62K.
Optima Capital first reported a position in Ironwood Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Optima Capital's Ironwood Pharmaceuticals position peaked at $2.62K in Q4 2025.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.